CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Net Income (Annual): -105.37M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -105.37M |
| December 31, 2022 | -106.00M |
| December 31, 2021 | -90.00M |
| December 31, 2020 | -50.99M |
| December 31, 2019 | -102.81M |
| December 31, 2018 | -72.55M |
| Date | Value |
|---|---|
| December 31, 2017 | -27.56M |
| December 31, 2016 | -26.67M |
| December 31, 2015 | -15.53M |
| December 31, 2014 | -31.92M |
| December 31, 2013 | -10.07M |
| December 31, 2012 | -11.26M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-106.00M
Minimum
2022
-50.99M
Maximum
2020
-91.03M
Average
-102.81M
Median
2019
Net Income (Annual) Benchmarks
| Gilead Sciences Inc | 5.665B |
| Assure Holdings Corp | -26.08M |
| Societal CDMO Inc (DELISTED) | -13.27M |
| AN2 Therapeutics Inc | -64.73M |
| Madrigal Pharmaceuticals Inc | -373.63M |